Identification of novel genetic variants and in-silico pathway analysis in patients with dilated cardiomyopathy / Rafezah Razali
Dilated cardiomyopathy (DCM), a genetically heterogeneous heart muscle disease is the third leading cause of heart failure. DCM usually leads to severe congestive heart failure and an increased risk of sudden cardiac death. The limitations of heart donor and transplant complications necessitate the...
Main Author: | Razali, Rafezah |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://ir.uitm.edu.my/id/eprint/29625/1/29625.pdf |
Similar Items
-
DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment
by: Alice Reid, et al.
Published: (2023-08-01) -
Surgical Repair of an Asymptomatic Giant Right Coronary Artery Aneurysm
by: Saleem Jahangeer, et al.
Published: (2013-07-01) -
Myocardial recovery evaluation from ventricular assist device in patients with dilated cardiomyopathy
by: Takayuki Gyoten, et al.
Published: (2022-08-01) -
Association of the <i>PSRC1</i> rs599839 Variant with Coronary Artery Disease in a Mexican Population
by: Martha Eunice Rodríguez-Arellano, et al.
Published: (2020-08-01) -
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
by: Benedikt Mayr, et al.
Published: (2016-02-01)